Breakthrough Understanding of Lyme Disease and Lyme Disease Treatment

Lyme Disease Misunderstood Leading to Unsatisfactory Lyme Disease Treatment Protocols

Lyme disease, often referred to as -the great imitator- is certainly one the most misunderstood and widely growing diseases within our borders. Because its symptomology resembles that of so many other illnesses and because the conventional medical community continues to be somewhat ignorant, afflicted patients are denied the Lyme disease treatment necessary to regain their health. Because Lyme disease is so blatantly misunderstood, routine treatment typically lasts a mere 4-6 weeks, with extensive treatment rendered unnecessary. As a result, a majority of insurance companies decline to approve appropriate treatment and residual Borrelia reemerges , so that patients often relapse with Lyme or dismally, Complex. To further cloud the issue, most patients diagnosed with Lyme disease are unaware of the full -complex- of co-infections and neurotoxins that dwell in their system - dooming the possibility of prescription medication as a viable, solitary Lyme disease treatment.

Before We Can Talk About Lyme Disease Treatment, We Must Understand What Lyme Disease Complex Is

In the arena of conventional medicine protocols, there is often conflicting opinion as to whether chronic Lyme disease is truly an authentic disease at all. Others recognize that patients certainly do suffer with Lyme disease symptoms associated with Borrelia contracted through tick bites. Unfortunately, most care providers do not have true LLMDs (Lyme Literate Doctors) on board who recognize the complexity, severity, and difficulty that is associated with Lyme disease treatment. To heighten understanding, the following represent the most common infections that assume a role in Lyme disease. They are all potential contributors to what Envita Medical Centers calls Lyme disease complex - a confluence of infections that may simultaneously include bacterial, viral, parasitic, and fungal co-infections that all require specific Lyme disease treatment and protocol customization to heal patients in the long term.

1.Borrelia (B. burgdorferi) - The premier infection found in Lyme disease patients which is often considered to be the tick-borne variety that produces Lyme disease itself. While it is a major contributor, Borrelia makes up but one of the numerous infections that create Lyme disease so that adequate treatment becomes an enormous challenge.

2.Bartonella - Bartonella henselae is the causative agent of the undesirable cat-scratch fever, endocarditis, and culprit promoting several other serious diseases in humans. These bacteria comprise one of Lyme disease Complex's most ardent co-infections. The bacteria are transferred by fleas, body lice, and ticks - with ticks being the greatest source of human bartonellosis infection, often accompanied by Lyme disease. Sand flies carry the bacteria in Peru's Andes Mountains, Colombia, and Ecuador while human body lice carriers appear in droves throughout the world. The European sheep tick is a known carrier and five different species of Bartonella have been detected in nearly 20 percent of I. Pacificus ticks collected in California.

3.Epstein-Barr (HHV-4) - This is a common human herpes virus that will infect virtually the entire population at some point in their lifetimes. It is possible for EBV to remain dormant in the body throughout the entire length of an individual's life span. Typically, the disease is transmitted via saliva and takes thirty to forty-five days to present with symptoms - if it ever does at all. During this juncture, the host is most likely to be contagious. However, when these infections endure as seen in chronic fatigue patients it becomes essential to test for chronic Lyme disease complex and its co-infections and immunity. is warranted as multiple infections can often awaken dormant infections such as Epstein-Barr.

4.Cytomegalovirus (CMV) - Approximately 80 percent of adults our country are infected with cytomegalovirus (CMV). It is a recognized member of the herpes family and shares the irascible ability to remaining alive, yet dormant, in the human body for the life of its human host. Rarely does CMV become active unless the immune system is infiltrated - as it can easily be (and most often is) with Lyme disease infections overwhelming the immune system.

5.Babesiosis- Intraerythrocytic parasite Babesia microiti causes Babesiosis, an infection that festers inside red blood cells. It is transmitted by the particular tick that transmits B. burgdorferi, the causative agent of Lyme disease. Forty one percent of patients combating Babesia develop serious complications which may include acute respiratory failure, disseminated intravascular coagulation, congestive heart or renal failure. Complex babesiosis is regularly linked with the presence of severe anemia and high parasitaemia levels. Chronic babesia has been known to promote cardiovascular, kidney, and liver problems in patients. Babesiosis is clearly a detrimental component of Lyme disease. It requires testing and, if advised, covered with a comprehensive Lyme disease treatment.

6.Human Herpes Virus 6 - Lyme disease complex may also include human herpes virus 6 (HHV-6) has undisputedly become one of the most widespread members of human herpes viruses and presents in two related variants: HHV-6A and HHV-6B. HHV-6 is charted to attack specific cells including but not limited to CD 4 lymphocytes, NKTs, oligodedrocytes, CD8 cells, and microglial cells. To summarize, this virus is immune suppressive and also activates other viruses in the process. While HHV-6 can remain latent for long periods of time, it can surely reactivate and cause infection quickly. A comprehensive Lyme disease treatment must be implemented in an effort to combat HHV-6 and other Lyme disease complex infections.

7.Ehrlichiosis - Ehrlichiosis is a resistant Lyme disease co-infection caused by rickettsial-type (specific bacteria) organisms that comes in two specific forms; Human Monocytic Ehrlichiosis (HME) and Human Granulocytic Ehrlichiosis (HGE). In a plethora of cases, Ehrlichiosis is self-limiting and not fatal with death rates in large, unselected series ranging from 1 to 8 percent [3,6-8]. This contrasts sharply with the high death rate in patients who are immunocompromised. Characteristically, however, Lyme disease patients reside in the dangerous -immunocompromised- category. That is why it is essential for patients to receive an aggressive and comprehensive Lyme disease treatment plan.

8.Chlamydia pneumonia - Chlamydophila pneumoniae (formerly known as Chlamydia pneumoniae or CP) are bacteria which infect humans and can result in pneumonia. They are a type of Chlamydia . Chlamydophila pneumoniae has a complex life cycle and needs to compromise another cell to reproduce itself. The disease often emerged as a respiratory infection, residing relatively unnoticed in the body and spread with abandon to infect other tissues as nerves, brain, muscles, blood vessels and even cells of the immune system, the macrophages. CP itself produces at least two toxic substances that prompt tissue destruction and inflammatory burden, as well as a chronic immune activation to invade the body with a toxin load. CP survive in the cell similarly as a parasite sucks energy and continue to reproduce themselves. Therapy, however, must be administered effectively until CP is destroyed in all three stages, which halts re-infection and is a critical part of Lyme disease treatment in cases where CP is present.

9.Candida - The most common organism implicated in fungal infections is the ubiquitous Candida, which is found in the human digestive tract, mouth, and genital region (Eggiman P et al 2003). Under normal circumstances, levels of Candida are reigned in by beneficial bacteria. However, if the bacteria-fungus balance is upset, by the use of antibiotics for example, or if the immune system is compromised, an overabundance of Candida can occur, resulting in infection. As the immune system is always compromised by the presence of chronic Lyme disease - the presence of Candida must be aggressively minimized in a comprehensive Lyme disease treatment.

As blatant as the above maladies seem, it is equally reasonable to point out that only 13% of infections that exist around the globe have actually been identified. Among these are zoonotic infections (those received from animals) - making Lyme disease treatment among the most complex to approach.

The Reality of Lyme Disease and Lyme Disease Treatments That Can Actually Work

If Lyme disease is detected early, it can be treated rather well with a realistic course of antibiotics. However, in a huge majority of cases, Lyme disease is not addressed by either the patients or their physicians at its onset - if they do at all. For patients who have had Lyme disease for more than a year, significantly more aggressive Lyme disease treatment must be authorized.

The standard prescription of antibiotics is categorically deemed insufficient when treating Lyme disease complex or as a sole Lyme disease treatment. Antibiotics do not help the body to destroy the mycotoxins or BLP (bacteria lipoprotein neurotoxins) caused by Borrelia, nor are they effective in treating the various viral, fungal, and parasitic co-infections attendant to Lyme disease. These co-infections are existent in some random combination in virtually every Lyme disease patient and must be dealt with in any worthy Lyme disease treatment.

To be clear, is not uncommon to notice four or more combinations of infections in chronic Lyme disease patients. Often months, or perhaps even years of treatment are incumbent to remove the stubborn Borrelia from the body - not to mention the multitudes of other attackers liberated by the presence of Lyme disease complex in the body. Chronic Lyme disease treatment requires an organized/customized program that includes reestablishing immune function and status for patients. Simply administering medication will not be successful and can even complicate matters for the worse. With a degree of certainty, practitioners who attempt to treat patients using anti-malaria drugs such as plaquenil, routinely fail as they do not address the immune system.

Chronic Lyme Disease Awareness and Effective Lyme Disease Treatment

Treatment of Lyme disease must be aimed at more than just the infections. Reducing inflammation, supporting the immune system, detoxification of BLP's, and addressing hormone deficiencies are in sync with a comprehensive chronic Lyme disease treatment plan. If patients are taking other medications or pain reducers, a delicate approach is needed to transition them to improved quality of life. Moreover, when patients indicate they have Lyme disease, or Lyme disease doctors assess patients - it is a recognition that they are dealing with a combination of infections, as well as an immune compromised state. While the infections present may vary from case to case, the dilemma is Lyme disease complex, or "a combination of infections-.

Envita's Experience is the Difference for Lyme Disease Patients and Life-changing Lyme Disease Treatment

Envita has worked in the field of Lyme disease research and Lyme disease treatment for nearly a decade. Our experiences have prompted more efficient, effective progress in Lyme disease treatment. At Envita, we address and examine all factors of Lyme disease, assuming that handling Lyme's co-infections are just as critical as direct treatment of the primary disease. Understanding the concept of co-infections and body's homeostasis imbalances is the reason why we name it Lyme disease complex and why Envita leads the all nations in effective Lyme disease treatment.

To further complicate matters, many Lyme disease infections live within the red and white bloods cells making them very stealth and expectedly, extremely difficult to treat. They can deter the body's immune defenses and reproduce within the healthy cells. Envita takes advantage of special shuttling agents to effectively address and treat these pervasive infections.

Lyme Disease Treatment and Complications of Lyme Disease

There has been much discussion about Bioflim communities that protect the infections from the absolution of medications. In many cases these Biofilm communities must be stripped and diminished through proper treatment and lifestyle changes.

Another scenario worthy of consideration, as it pertains to Lyme disease treatment, is self-synergistic replication. In this situation, many infections can communicate with and embellish or activate, the replication of other viruses already present in the body. All the while, the patient must engage numerous symptoms that may present as digestion problems, cognitive difficulties, chronic pain, sleep deprivation, and hormonal imbalances - just to list a few.

Does Chronic Lyme Disease Exist and is Lyme Disease Treatment Necessary

Lyme disease does undeniably have status. And even though many researchers will say the patient really doesn't have Lyme disease in the classical laboratory form - patients still often suffer duress from a combination of the infections we mentioned earlier - and they need to all be treated simultaneously to really provide effective and sustained relief for patients.

It is also of value to realize that many laboratory tests provide false negatives indicating the test comes back negative when the patient actually has an infection(s) present. Some of the most common reasons are immune systems that are frequently too weak to mount a proper antigen test. However, if an immune system challenge is conducted, one may see a positive test return for these patients. Additionally, many of these infections do live intra-cellularly and as a result return with false negative results.

At Envita, we have instituted a strong combination of tests to identify specific immunological factors and a comprehensive clinical overview to help patients find and treat all the factors of the Lyme Disease complex.

Envita's Approach to Tackling Lyme Disease and Identifying the Ideal Lyme Disease Treatment for Each Patient

As Lyme disease is so complex, extensive and comprehensive Lyme disease treatment is ostensibly vital. At Envita, Lyme disease treatments are not limited to antibiotics, rather administered in conjunction with aggressive natural therapies from all over the world.

As part of our Disease Solutions Program, we take an integrative approach to Lyme disease treatment, utilizing anti-viral, anti-parasitic, and anti-fungal approaches - depending on the co-infections and symptoms present in each affected patient. By addressing all Lyme disease complex factors, we achieve significantly better results with our incomparable Lyme disease treatments.

We implement innovative treatments to help patients achieve full comprehension of their disease, thereby providing them with the ability to turn the corner. Our intense approach to treatment helps speed healing time, increase quality of life, and minimize the recurrence of Lyme disease. To learn more about our Lyme disease treatment protocols or more about Lyme disease in general, please contact us at Envita Medical Centers today.

A Powerful Approach to Personalized Medicine Strategies for Cancer Treatments, Chronic Disease, Contact us today for more information. At Envita you can find the help you need to improve the quality of your life.